You are here: Industry Insights > HCQ

News List

Dr. Steven Hatfill: Pandemic Report Single Point Failure II prnewswire
May 28, 2021
Called to the White House in the early days of the pandemic as an outside advisor to the Executive Office of the President, DR. STEVEN HATFILL witnessed the destruction of the National Pandemic Plan.
Novartis stops HCQ trial against COVID-19 citing participant shortfall expresspharma
June 22, 2020
The move comes in the wake of US FDA’s decision to EUA for hydroxychloroquine and chloroquine against COVID-19.
Researchers Overdosing COVID-19 Patients on Hydroxychloroquine, States Association of American Physicians & Surgeons (AAPS) prnewswire
June 18, 2020
Until President Trump suggested that hydroxychloroquine (HCQ, Plaquenil™) might help COVID-19 patients, it was generally considered a very safe drug, observes the Association of American Physicians & Surgeons (AAPS).
US FDA warns against co-administration of remdesivir and chloroquine or HCQ expresspharma
June 17, 2020
The drug regulator informs that this may reduce the antiviral activity of remdesivir and lessen the effectiveness of COVID-19 treatment.
Government lifts export restrictions on HCQ APIs, formulations expresspharma
June 11, 2020
The government has lifted export restrictions on active pharmaceutical ingredients (API) and formulations of hydroxychloroquine (HCQ).
Local API production in India for COVID-19 repurposed drugs may offer competitive advantage: GlobalData expresspharma
June 08, 2020
The advantages will be in terms of supply and price for the formulations manufactured in India, be it remdesivir, favipiravir or hydroxychloroquine (HCQ).
Sterling Begins HCQ Production in UK contractpharma
May 12, 2020
Partners with Accord Healthcare for the manufacture of potential COVID-19 treatment.
AMRI Increases HCQ Production in U.S. contractpharma
May 05, 2020
Contract research, development and manufacturing organization, AMRI, said in the immediate and near term, it is increasing production of hydroxychloroquine sulfate active pharmaceutical ingredient (API).
India agrees to sell hydroxychloroquine to Malaysia to help fight COVID-19 expresspharma
April 16, 2020
India has agreed to sell hydroxychloroquine (HCQ) tablets to Malaysia for use in the treatment of COVID-19 patients, a Malaysian minister told Reuters recently, with New Delhi partially lifting its bar on exports of the anti-malarial drug.